Assembly Biosciences, Inc. (ASMB) Misses Q3 EPS by 3c

Assembly Biosciences, Inc. (NASDAQ: ASMB) reported Q3 EPS of ($0.27), $0.03 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Assembly Biosciences, Inc. (ASMB) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral